ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

New Biomedical Research Panel Accepts Broad Mandate. May Suggest Separate Health Dept.

February 28, 1975

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

In Brief: Congresswomen Receive FASEB Awards for Public Service for Support of NIH

May 2, 1997

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

Low-Income Women Lack Mammography Access: Survey

May 14, 1993

Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups

April 18, 1975